Glioblastoma multiforme (GBM)
Clinical trials for Glioblastoma multiforme (GBM) explained in plain language.
Never miss a new study
Get alerted when new Glioblastoma multiforme (GBM) trials appear
Sign up with your email to follow new studies for Glioblastoma multiforme (GBM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a targeted antibody take on glioblastoma?
Disease control OngoingThis phase 1 trial is testing whether amivantamab, an antibody drug given by IV, is safe and tolerable for people with high-grade malignant brain tumors like glioblastoma. The study enrolls about 12 patients with recurrent glioblastoma or certain molecular subtypes. Participants …
Matched conditions: GLIOBLASTOMA MULTIFORME (GBM)
Phase 1 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New drug combo hopes to fight tough cancers in kids and young adults
Disease control OngoingThis study tests a combination of two drugs, cobolimab and dostarlimab, in children and young adults (up to age 21) with advanced solid tumors that have not responded to other treatments. The goal is to find the safest dose and see if the combination can shrink tumors. The study …
Matched conditions: GLIOBLASTOMA MULTIFORME (GBM)
Phase 1/2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC